Adolescent Lupus Nephritis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Adolescent Lupus Nephritis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Adolescent Lupus Nephritis trials you may qualify forThis phase II, randomized, double-blind, placebo-controlled study is designed to evaluate the safety, efficacy and pharmacokinetics (PK) of obinutuzumab in adol…
This is a single-center, single-arm, open-label phase 1/2 study of CART19 in children and young adults with refractory Systemic lupus erythematosus (SLE), inclu…
The purpose of this study is to assess the long-term safety and tolerability of voclosporin for up to an additional 12 months following completion of treatment…
The purpose of this study is to assess the efficacy and safety of voclosporin compared to placebo in achieving renal response following 24 weeks of therapy in a…
Evaluation the efficacy of chloroquine and hydroxychloroquine in the treatment of proliferative lupus nephritis class III and IV in children and adolescents and…